Elizabeth W. LaPensee, Ph.D.
Affiliations: | 2008 | University of Cincinnati, Cincinnati, OH |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Elizabeth LaPensee"Parents
Sign in to add mentorNira Ben-Jonathan | grad student | 2008 | University of Cincinnati | |
(Mechanisms of chemoresistance in breast cancer and liposarcoma.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kobayashi LC, Westrick AC, Doshi A, et al. (2022) Reply to "Noncancer comparators in cancer survivorship studies". Cancer |
LaPensee EW, Ben-Jonathan N. (2010) Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocrine-Related Cancer. 17: R91-107 |
LaPensee EW, LaPensee CR, Fox S, et al. (2010) Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells. Cancer Letters. 290: 167-73 |
LaPensee EW, Schwemberger SJ, LaPensee CR, et al. (2009) Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase. Carcinogenesis. 30: 1298-304 |
Lapensee EW, Tuttle TR, Fox SR, et al. (2009) Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environmental Health Perspectives. 117: 175-80 |
Ben-Jonathan N, LaPensee CR, LaPensee EW. (2008) What can we learn from rodents about prolactin in humans? Endocrine Reviews. 29: 1-41 |
LaPensee EW, Reddy SP, Hugo ER, et al. (2007) LS14 cells: a model for chemoresistance in liposarcoma. Cancer Biology & Therapy. 6: 519-24 |